DHR — Danaher Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Danaher, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	8-K
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	24,802	26,643	23,890	23,875	24,568
Cost of Revenue
Gross Profit	15,239	16,188	14,034	14,231	14,523
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	18,516	19,016	18,657	19,012	19,878
Operating Profit	6,286	7,627	5,233	4,863	4,690
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	6,511	7,146	5,044	4,646	4,233
Provision for Income Taxes
Net Income After Taxes	5,447	6,328	4,221	3,899	3,600
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	6,433	7,209	4,764	3,899	3,614
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	6,347	7,123	4,743	3,899	3,614
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	7.42	8.37	5.9	5.68	6.04
Dividends per Share